Savior Lifetec Corporation announced on May 23, 2013 that the injection plant (IP) in Tainan, Taiwan was deemed as complying with the Good Manufacturing Practice guidelines for medicinal products laid down in Directive 2003/94/EC. The authorized manufacturing operations are aseptically prepared sterile products. The inspection by the competent authority of Spain/France was completed during the period of December 10, 2012.